ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study

Thursday, August 22, 2019

Submitted by

Mark Ferguson

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://www.annalsthoracicsurgery.org/article/S0003-4975(19)30864-1/abstract?dgc…

Author(s)

Tara R. Semenkovich, Melanie Subramanian, Yan Yan, Wayne L. Hofstetter, Arlene M. Correa, Stephen D. Cassivi, Matthew L. Inra, Brendon M. Stiles, Nasser K. Altorki, Andrew C. Chang, Alexander A. Brescia, Gail E. Darling, Frances Allison, Stephen R. Broderick, Eric W. Etchill, Felix G. Fernandez, Ray K. Chihara, Virginia R. Litle, Juan A. Muñoz-Largacha, Benjamin D. Kozower, Varun Puri, Bryan F. Meyers

In this multiinstitutional retrospective study, administration of adjuvant chemotherapy for patients with persistent nodal disease after induction therapy and esophagectomy was associated with improved survival.